Back to search results

Comparing Bone Marrow Collection Systems for Hip Bone Loss

This study is comparing two ways to collect bone marrow liquid: the standard Zimmer Biomet Biocue system and the new Marrow Cellutions system™. Researchers want to see which method collects more stem cells. You might be able to join if you are 18-50 years old and are having hip surgery for bone loss (hip arthropathy), dead bone tissue (avascular necrosis of bone), or bone cysts (subchondral cysts). People with certain blood conditions, diabetes, or a history of bone marrow diseases cannot participate. The main goal is to measure the total number of stem cells collected from each method after 6 months. The current recruitment status is unclear.

Study design
This interventional study plans to enroll 6 participants. It compares two different bone marrow collection systems.
What's involved
You would have bone marrow liquid collected from both hips during your hip surgery. This involves using the Zimmer Biomet Biocue system on the surgical hip and the Marrow Cellutions system™ on the non-surgical hip.
Compensation
Not stated in the trial record.
Follow-up
The study will assess the number of stem cells collected at 6 months after the procedure.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06388993

Marrow Cellution™ vs. Traditional BMA Harvest Project

Recruiting
NAAges 18–50InterventionalTreatment
Ohio State University
~6 participants
Updated 2026-04-01 on ClinicalTrials.gov
What's tested:Bone Marrow Collection

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Assess overall number of stem cells collected from each aspiration method
Measured over 6 Months

Conditions

Hip Arthropathy
Avascular Necrosis of Bone
Subchondral Cysts

Explore related trials

Avascular Necrosis of BoneRepair of hipSubchondral bone cyst

NCT06388993

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Jameson Crane Sports Medicine Institute

    Columbus, Ohiostudy coordinator listed

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Study leadership

  • William K Vasileff, MD · PRINCIPAL_INVESTIGATOR · Ohio State University

Who to contact

Michael Keller
[email protected]
614-293-2410
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

patients aged 18 - 50
patients undergoing hip arthroscopy for subchondral bone cysts and/or avascular necrosis

Exclusion

patients with a history of hematologic issues including anemia and sickle cell anemia
patients with a history of leukemia, lymphoma, or other bone marrow related diseases
patients with diabetes
patients with a history of bone marrow aspirate

What this trial measures

  • Assess overall number of stem cells collected from each aspiration method6 Months

    Compare total amount of stem cells collected from each sample